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Abstract
Scaffolds for osteochondral tissue engineering should provide mechanical stability, while offering specific signals for
chondral and bone regeneration with a completely interconnected porous network for cell migration, attachment, and
proliferation. Composites of polymers and ceramics are often considered to satisfy these requirements. As such methods
largely rely on interfacial bonding between the ceramic and polymer phase, they may often compromise the use of the
interface as an instrument to direct cell fate. Alternatively, here, we have designed hybrid 3D scaffolds using a novel concept
based on biomaterial assembly, thereby omitting the drawbacks of interfacial bonding. Rapid prototyped ceramic particles
were integrated into the pores of polymeric 3D fiber-deposited (3DF) matrices and infused with demineralized bone matrix
(DBM) to obtain constructs that display the mechanical robustness of ceramics and the flexibility of polymers, mimicking
bone tissue properties. Ostechondral scaffolds were then fabricated by directly depositing a 3DF structure optimized for
cartilage regeneration adjacent to the bone scaffold. Stem cell seeded scaffolds regenerated both cartilage and bone in vivo.
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Introduction
Osteochondral defects are typically derived from congenital
diseases or traumatic events in young patients and from osteoarthritis
in old individuals. This results in associated pain, joint stiffness and
instability, and often leads to the replacement of joint functionality
with prosthesis. Although bone tissue has the capacity to regenerate,
bone repair is impaired in many pathological situations. Further-
more, cartilage has a poor capacity to regenerate itself due to its
avascular nature and to its intrinsic composition. Immobilization of
patients is often the last stage of these degenerative and painful
processes. Therefore, there is a critical need to develop technologies
to promote bone and chondral healing. Autografts–tissues trans-
planted from one part of the body to another in the same patient,
namely here bones or osteochondral plugs–are the most common
treatments for osteochondral defects. However, clinical use involves
some difficulties including septic complications, viral transmission,
and morbidity in the location where tissue is harvested [1,2]. A
possible solution in terms of availability would be the use of
allografts–tissues transplanted from one part of a donor’s body to the
same or another part of a recipient patient. Yet, these may be
associated to risks of disease transmission, and complications in
shaping. Other significant additional limitations of allografts are
delay in remodeling of the bony part by the host and a lack of
integration with the surrounding chondral tissue. Furthermore, in
the case of very large defects the allograft may remain in the implant
site throughout the patient’s life, creating an area more prone to
fracture or infection [3–5].
These issues have justified the development of 3D scaffolds
employed for tissue regeneration, which are an attractive
alternative when used alone or in combination with cells to
restore the joint functionality [5–7]. Osteochondral scaffolds
typically comprise a cartilage and a bone compartment. Chondral
scaffolds are generally formed by polymeric foams or textile
meshes [8–12], while bone substitutes include either biomaterials
mimicking the composition of bone, i.e. calcium phosphate
ceramics simulating the bone mineral composition [13–15], or
demineralized bone matrices (DBMs) matching the organic
composition [16–18]. Despite the fact that these materials have
demonstrated satisfying cartilage and bone forming capacities,
their mechanical properties may not always be optimal for
implanting in load bearing sites. In particular, for the bony site
under high loads, ceramics are often too brittle and can be subject
to fracture, whereas DBMs are very flexible and may require the
patient to be temporarily immobilized. A possible solution to
overcome the mechanical drawbacks displayed by ceramics and
DBMs is to combine and integrate them with a polymeric matrix.
Studies to date have focused on the incorporation of ceramics and
polymers by interspersing the polymeric phase into the ceramic
phase–and vice versa–to finally obtain a homogeneous composite
scaffold [19–22]. However, this often results in scaffolds with poor
polymeric-ceramic bonding, limited control over composite
processability and mechanical properties, and loss of interface
properties. Furthermore, during the interspersion of the two
phases some of the pores can be blocked, typically due to the use of
solvents, resulting in a reduction of interconnected pores and lack
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of cell migration [4,19,23]. In this respect, rapid prototyping
techniques can offer an optimal solution in terms of mechanical
properties modulation as they demonstrated to effectively control
the structural parameters of 3D scaffolds [23–25]. These
technologies can process different biomaterials and require
minimal or no use of solvents. In addition, they allow the creation
of custom-made scaffolds based on patients’ image datasets of the
damaged area. These characteristics make rapid prototyping a
unique tool to develop readily available products in the clinics.
Here, we propose a novel concept to design hybrid scaffolds where
the biomaterials are not chemically or physically bonded, but
assembled in a single three-dimensional (3D) construct with
preserved pore network interconnectivity and interfacial properties.
By integrating different rapid prototyping technologies, it was
possible to create scaffolds for osteochondral tissue engineering
where the chondral scaffold was directly connected to the bone
compartment by 3D fiber-deposition (3DF). The bone construct was
formed by ceramic particles of designed shapes captured into a
flexible polymeric 3DF matrix (3DFM). A DBM gel was infused and
the scaffolds freeze-dried resulting in a foamy interspersed phase that
acted as a mechanical cushion while providing further bone
regeneration properties. The bone scaffold was finally interlocked
to an optimized 3DF scaffold for cartilage regeneration [26,27]
through intertwined concentric polymeric fibers mimicking the
tidemark area–region delimiting hyaline cartilage from subchondral
bone–of the osteochondral natural architecture. The resulting hybrid
constructs combined the flexibility of polymers and DBMs with the
mechanical strength of ceramics while maintaining the individual
osteochondral formation capacities of the single biomaterials
assembled. These polymer-ceramic scaffolds were evaluated for
their bone and cartilage regeneration potential and were shown to
support in vivo osteochondral formation. Poly(ethylene oxide2ter-
ephthalate)/poly(butylene terephtalate) - (PEOT/PBT) copolymers -
were used to fabricate the polymeric matrices. These polyether-esters
are biodegradable thermoplastic elastomers, which have favorable
physical properties [28–30], and a suitable biocompatibility both in
vitro and in vivo [31–35]. Biphasic calcium phosphate (BCP) was
chosen as a ceramic due to its osteoconductive and osteoinductive
properties depending on its physicochemical and microstructural
properties [36–39].
Results
The composition of BCP particles was analyzed by X-ray
diffraction (XRD) (figure 1c) and was comprised of 24.6% tricalcium
phosphate (TCP) and 75.4% hydroxyapatite (HA). Fourier trans-
form infrared spectroscopy (FTIR) confirmed BCP composition, as
described elsewhere [38]. DBMs were obtained by acid extraction of
the mineralized component of bone, while maintaining the collagen
and non-collagenous proteins. Among these proteins, the presence of
morphogenic factors is known to confer DBMs osteoinductivity,
which contributes to direct the differentiation of local mesenchymal
stem cells into the osteogenic lineage [40–42].
Two different design strategies (designs A and B) were
considered for the bone compartment of osteochondral scaffolds
(figure 1). In the bone compartment of design A, designed particles
were captured in the pores of a 3DF polymer matrix (PEOT/PBT
1000/70/30) while in design B a BCP core was surrounded by
such a matrix. In both designs the cartilage compartment consisted
of the same polymer matrix, but of different composition (300/55/
45). The assembled scaffolds were analyzed by scanning electron
microscopy (SEM) and evaluated in terms of ceramic-polymer
fitting, DBM infusion, and overall construct integrity (figure 2).
The weight and volume percentage of BCP included in the 3D
PEOT/PBT matrix depended on the particles geometry (support-
ing information, table S1). Pillar particles were found to better fit
in the pores of 3DFM (figure 2a), resulting in the highest BCP
weight percentage of 6163.15% (n= 3). This corresponded to a
volume fraction of 27.9860.81%. SEM revealed a complete
infusion of the BCP macro porous structure with DBM (figure 2c).
For both the designs, a final infusion in a DBM gel was performed
to further integrate the different components assembled in the
scaffolds (figure 2d). The final constructs had a pore distribution
from 1.4361.25 mm in the ceramic phase to 135162.4 mm in the
polymeric matrix and a total porosity of 79.3561.9% in design A,
while a pore distribution from respectively 1.4361.25 mm to
5316237 mm and a total porosity of 88.9561.26% in design B
(supporting information, table S2).
Osteochondral constructs with or without an interlocking
system were then fabricated by directly depositing the chondral
compartment onto the bone scaffold with 3DF (figure 3). Due to
the different swelling properties of the two PEOT/PBT compo-
sitions (bone= 1000/70/T30–cartilage = 300/55/45), instability
at the interface of the two compartments might occur (figure 3a).
Therefore, an interlocking system made of intertwined concentric
1000/70/30 and 300/55/45 fibers was deposited at the interface
between the bone and the chondral parts of the construct (figure 3b
and 3c). SEM analysis revealed a fiber diameter of 170615 mm, a
fiber spacing of 605612 mm, and a layer thickness of 148610 mm
for the cartilage compartment scaffolds. This corresponded to a
porosity of 7462% and, consequently, to a dynamic stiffness of
approximately 13 MPa, as calculated from previous studies [26].
The 3D hybrid scaffolds fabricated for the bone compartment of
the osteochondral construct were mechanically characterized by
measuring the bending and compressive storage modulus (or
dynamic stiffness E9) and the breaking stress and strain. In design
A (n = 3), the bending dynamic stiffness of the bare 3DFM scaffold
was 0.13460.035 MPa (figure 3d). When the custom-made BCP
particles were press-fitted into the pores of the 3DFM scaffolds the
bending stiffness significantly increased to a maximum of
18.9960.14 MPa for pillar particles (p,0.05), depending on the
shape of the particles. Similarly in compression (figure 3e), the
dynamic stiffness significantly increased from 0.69260.16 MPa for
bare matrices to 0.93560.165 MPa for irregular particles, to
37.9666.14 MPa for truncated conical particles. In design B
(figure 3f), the compressive stiffness of the hollow 3DFM cylinder
was 1.160.34 MPa, while the stiffness of the whole construct was
7.861.68 MPa (n = 3, p,0.05). The stress at break was also
dependent on the hybrid scaffold design and varied from
0.5260.14 MPa for irregular particles to 14.0161.19 MPa for
pillar particles. The strain at breaking varied from 9.9261.78% to
33.7460.49%, but did not appear to depend on the particle design
(figure 3g). DBM and 3DFM alone did not break under
compression.
As a preliminary study, 3DF polymeric matrices were infused
with DBM and assessed in vivo for their osteoinductive and
osteoconductive properties (figure 4). In an intramuscular rat
model (n = 3), new bone formation was observed after 4 weeks in
apposition with DBM (figure 4a). In contrast, no bone apposition
was detected in polymeric matrices alone, thus highlighting the
osteoinductive properties of DBM. To evaluate the full potential of
polymeric-DBM biomaterial assembly, scaffolds were implanted in
an ulna defect in rabbits (n = 4) for 6 weeks. The bone defect was
repaired within this time frame and consistently filled with new
bone and marrow (figure 4b). In further efforts to regenerate both
cartilage and bone, osteochondral scaffolds as in design A with no
DBM infusion were seeded with mesenchymal stem cells (MSC)
and evaluated for their cartilage and bone forming capacities
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subcutaneously in (n = 5) nude mice (figure 5). MSCs were
aggregated in chondrogenic medium 2–3 days before seeding
and resuspended in the cartilage compartment with MatrigelH,
while maintaining a rounded morphology. In the osseous part cells
were seeded undifferentiated. Here, they were homogeneously
distributed and attached throughout the scaffolds displaying a flat
and spread morphology (figures 5a and b). After 25 days of
subcutaneous implantation, the two components maintained their
structural integrity. Histological analysis revealed de novo bone
formation in the bone part (figure 5c).
Tissue generation took place in direct apposition to the ceramic
surface. Osseous tissue was composed of a mineralized matrix.
Osteocytes could be detected embedded in the matrix and layers
of osteoblasts were seen lining the outer edges of the newly formed
bone. Bone marrow like tissue characterized by haematopoietic
cells, blood vessels and fat could also be observed in most of the
implants. In few cases, hyaline cartilage-like islands appeared
within the pores of the BCP (figure 5d). In the chondral part
histological staining revealed the presence of cartilage like tissue.
Cells exhibited a round morphology and were located in lacunae
(figure 5e). Mineralized matrix within the chondral part was also
noticed. Clearly, hypertrophic cells were still distinguishable in the
center of the mineralized nodules suggesting endochondral
ossification (figure 5f). Control grafts implanted without cells did
not show any evidence of osseous or chondral structures.
Discussion
In this study, we have shown a novel concept based on biomaterial
assembly to design and fabricate 3D osteochondral scaffolds that
posses the mechanical flexibility of polymers and DBMs, and the
strength of ceramics. The rapid prototyping approach used in the
design allowed the creation of scaffolds with a completely
interconnected and accessible porous network. Whereas ceramics
and DBMs have different mechanical drawbacks, the hybrid
composite of these two bone graft substitutes with polymeric matrix
has variable stiffness depending on the ceramic particles and on the
overall construct design. Strain didn’t depend on scaffold design and
showed approximately a 3-fold increase with respect to BCP
scaffolds, while stress varied from a 14-fold decrease for irregular
particles to a 2-fold increase for pillar particles as compared to BCP
(figure 3g). The variable increase in stiffness and breaking stress
might be linked to the different packing degree of the ceramic in the
polymeric matrix, resulting in a progressively higher coupling of the
two materials. The increasing fit in the polymer, thus, resulted in a
more efficient strengthening of the construct increasing the overall
stiffness and the stress at break. At the same time, the presence of
DBM and of the polymer introduced a higher flexibility in the
constructs due to their intrinsic mechanical properties, causing an
increase in the deformation at break. With increasing BCP volume
percentage in the hybrid 3D scaffolds, the bending stiffness increased
Figure 1. Schematic draw of the scaffold process fabrication for (a) design A and (b) design B. (a) P = Pillar; TC= Truncated Cone;
S = Spherical. (b) an optical micrograph of the porous structure of the 3DF hollow cylinder is shown; scale bar: 400 mm. (c) X-ray diffraction pattern
and (d) FTIR spectrum of rapid prototyped BCP particles where characteristic peaks are highlighted. Shrinkage following sintering of BCP particles
varied from 760.7% to 1861.9%.
doi:10.1371/journal.pone.0003032.g001
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accordingly (figure 4d). This was expected, since BCP is the stiffest
component in the assembly. A similar trend was seen for the
compressive stiffness, the highest value measured when truncated
conical ceramic particles were incorporated in the polymeric matrix
(figure 3e). The experimental measured values of the bending
stiffness were also in the same range of the calculated stiffness from
the Reuss-Voigt model for dispersed particle composites. This might
suggest that the assembly of the different biomaterials proposed here
can be considered close to a composite when subjected to a flexion
load, although it cannot be strictly defined as such. It is clear that the
hybrid scaffolds do not mechanically respond as real composites
when their mechanical behavior in compression is considered. In this
case the theoretical and experimental values do not follow the same
power law (supporting information, Figure S1 and Table S3).
As reviewed by Athanasiou et al. [3], cancellous bone has a
bending modulus varying between 49 MPa and 336 MPa, and a
compressive modulus varying between 12 MPa and 900 MPa.
Cortical bone has a bending modulus ranging from 5.44 GPa to
15.8 GPa, and a compressive modulus ranging from 4.9 GPa to
27.6 GPa. The variations are related to different bone sources,
locations within those sources, and mechanical testing conditions.
Cancellous bone has a strength varying between 0.15 MPa and
10.2 MPa, while cortical bone has a strength ranging from
90 MPa to 193 MPa. If the stiffness and stress/deformation at
break of the hybrid 3D assembled scaffolds are compared to those
of cortical and cancellous bone, constructs with pillar or conical-
cylindrical ceramic particles better approach the mechanical
behavior of cancellous bone. Yet, the modulation in mechanical
properties associated to different ceramic particle geometry in the
hybrid 3D scaffolds gives a further degree of freedom to these
constructs while maintaining the biological properties of the
assembled biomaterials. For example, the use of specific ceramic
particles can be envisioned to fit the cancellous bone mechanical
properties of each patient in customized applications. Cortical
bone still has a much greater stiffness and strength as compared to
the scaffolds here presented.
For these reasons, osteochondral scaffolds with pillar BCP
particles were selected for in vivo studies and seeded with MSCs,
known to be able to differentiate into musculoskeletal tissues under
the appropriate stimuli. The use of MSCs is also advantageous
regarding clinical applications, since they can be easily isolated by
bone marrow aspiration from the iliac crest under partial anesthesia.
In this study design, osteogenic differentiation was successfully
induced. Noteworthy, cells were not pre-differentiated, but formed
bone in vivo due to the osteoinductive properties of the BCP particles.
Cartilage like tissue within the pores of BCP was also observed. We
hypothesize that the enclosure of MSCs supported the regeneration
of cartilage-like tissue. Factors such as high cell density, condensation
and low oxygen concentration that favor the chondrogenic
differentiation of mesenchymal stem cells might have occurred
[43–47]. It has been shown that PEOT/PBT polymers favor
chondrocyte redifferentiation in vitro [48,49]. However, no chon-
droinductive properties could be detected so far. Therefore, unlike
for bone, MSCs intended for cartilage regeneration were pre-
cultured in chondrogenic medium for 48–72 hours. Not only
cartilaginous tissue was observed, but also mineralized matrix with
embedded osteocytes was found in the chondral part. Whereas the
presence of cartilage in the bone compartment may be explained
Figure 2. SEM micrographs of designs A (a, b) and B (c, d) integrated 3D hybrid scaffolds. (a) BCP particles inserted in the pores of a 3DF
1000PEOT70PBT30 matrix. (b) microstructure of ceramic particles sintered at T = 1150uC. (c) BCP cylinder infused with DBM after freeze drying. (d)
Particular of the whole construct after insertion of the two DBM foamy discs, the infused BCP cylinder in the hollow 3DFM scaffold, and final
lyophilization shows the integration of all the components. Scale bar: (a) 500 mm; (b) 10 mm; (c, d) 1 mm. Pillar particles (arrows) are shown here as an
exemplification. P =polymer.
doi:10.1371/journal.pone.0003032.g002
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Figure 3. Optical microscopy images of the osteochondral 3D scaffolds. Without the interlocking concentric fiber system (a) both
compartments could be separated easily. With the intertwined fibers (c) the osteochondral construct maintained its integrity (b) under mechanical
stress. Scale bar: 1 mm. Influence of the scaffold design on the bending (d) and compressive (e, f) storage modulus in designs A (d, e) and B (f). The
dynamic stiffness of the single components comprising the hybrid scaffold was also measured for comparison. (g) Stress and strain at break for
design A (influence of particle design), design B, and BCP. (*) Strength values for bone are taken from Athanasiou et al.[3]. All groups were
significantly different from each other (p,0.05). Particle shape legend: I = Irregular; S = Spherical; P = Pillar; TC= Truncated Cone.
doi:10.1371/journal.pone.0003032.g003
Figure 4. New bone formation in (a) rats and (b) rabbits. (a) Polymeric-DBM 3D scaffolds were implanted for 4 weeks intramuscularly in rats
and new bone (arrows) was formed in direct apposition of DBM. (b) When implatend in ulna defects, these scaffolds repaired the defect in 6 weeks
with re-establishment of bone marrow (thin black arrows). Polymer degradation was also visible at this time (yellow arrows). NB =new bone;
PA=polymeric 3DF scaffold; DBM=demineralized bone matrix.
doi:10.1371/journal.pone.0003032.g004
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through endochondral ossification, it is not yet clear why mineralized
matrix was formed in the chondral part of the scaffold. We
hypothesize that the presence of blood vessel subcutaneously in mice
and their possible ingrowth in the tissue-engineered constructs
creates a microenvironment favoring osteogenesis. In an orthotopic
location, where an osteochondral scaffold would ultimately be used,
the lack of vascular network in the articular cartilage plateau and the
proper mechanical loading environment may favor mature cartilage
formation with no mineralized matrix in the chondral compartment.
The proposed biomaterial assembly approach to fabricate
osteochondral scaffolds through the integration of rapid prototyp-
ing technologies brings its novelty as it combines cartilage and
bone compartments mechanically matching the natural tissues to
be restored with biomaterials that singularly showed to support
cartilage and bone tissue formation. The mechanical properties of
these constructs could be modulated depending on the assembly
design and matched both cartilage and cancellous bone stiffness
and strength, while maintaining interface properties. Bone and
cartilage were successfully regenerated in the two respective
compartments with a single stem cell source. Although further
light needs to be shed on the mechanism that brings mineralized
matrix formation in chondral scaffolds, these hybrid constructs
hold promises as candidates for osteochondral regeneration in
one-step surgery procedures.
Materials and Methods
Materials Characterization
Poly(ethylene oxide2terephthalate)/poly(butylene terephtalate)
(PEOT/PBT) copolymers, solubilized demineralized bone matrix
Figure 5. Osteochondral Scaffolds seeded with MSCs before (a, b) and after (c–f) subcutaneous implantation in nude mice. (a) Cell
aggregates in the chondral compartment maintained a rounded morphology typical of chondrocytes; insert shows stable aggregate formation after
48–72 hours in chondrogenic media. (b) Cell attached and spread on the BCP particles in the bone part; insert shows methylene blue staining of
attached cells on porous pillars. (c) Bone part of the osteochondral construct.: pores were filled with de novo bone (fuchsin red staining). Note the
embedded osteocytes and the osteoblasts laying at the outer edge of the mineralized matrix. (d) Occasionally, hypertrophic cells with positive
stained matrix could be seen in the pores (thionine). (e) Cartilage part of the osteochondral construct: Cartilage tissue could be observed in the
chondral part. Cells exhibit a round, chondrocyte-like morphology, locate din lacunae and surrounded by positive extracellular matrix (thionine
staining). (f) Hypertrophic cells in the center of mineralized matrix (fuchsin red staining) and embedded osteocytes could be also occasionally found.
Scale bar: (a, b) 50 mm; (c–f) 200 mm; Insert in (a): 250 mm; (b) 600 mm.
doi:10.1371/journal.pone.0003032.g005
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(DBM), and biphasic calcium phosphate (BCP) powder were
obtained from IsoTis Orthopaedics S.A. (Bilthoven, The Nether-
lands). The copolymer composition used in this study were
1000PEOT70PBT30 for the 3DF matrix (3DFM) of the bone
compartment and 300PEOT55PBT45 for the cartilage compart-
ment of the osteochondral scaffold where, following an
aPEOTbPBTc nomenclature, a is the molecular weight in g/mol
of the starting PEG blocks used in the copolymerization, while b and
c are the weight ratios of the PEOT and PBT blocks, respectively.
Design of the Bone Compartment Scaffolds
Tri-phasic scaffolds were fabricated by assembling BCP,
1000PEOT70PBT30, and DBM into monolithic constructs for
the bone compartment of the osteochondral scaffold. Two
different design schemes (A and B) were chosen for the scaffolds.
Design A consisted of fabricating a PEOT/PBT 3DFM that was
used as a carrier for BCP rapid prototyped particles, which were
press fitted into the scaffold pores. BCP particles were of pillar
(side: 1.6 mm; height: 4.3 mm), truncated cone (large base
diameter: 2 mm; small base diameter: 1.6 mm; height: 4 mm),
spherical (diameter: 1.8 mm) and irregular (between 1.4 mm and
2 mm in their maximum dimension) shapes (figure 1a). More
spherical and irregular particles were press fitted in the pores of the
3DFM scaffolds until covering the total thickness of the polymeric
matrix. Different ceramic particle shapes were considered to assess
the optimal amount of included BCP and the influence of the
particle geometry on mechanical properties, while maintaining the
flexibility of the construct. The 3DFM scaffold had a block shape,
with a square base of 10 mm, and a height of 3.15 mm. Since
1000PEOT70PBT30 is known to swell in an aqueous environment
[28–30], the scaffolds were under dimensioned to match exactly
the BCP designed particles in a wet milieu.
In design B, a BCP cylinder (5 mm in diameter by 3 mm in
height) was pre-soaked in a DBM gel (2.6% w/v in a 4.75% v/v
methanol in demineralized water solution) and subsequently
lyophilized. The cylinder was ‘‘sandwiched’’ by two discs of DBM
foam (5 mm in diameter by 1 mm in height) and the construct was
inserted in a hollow cylindric container of PEOT/PBT made by
three-dimensional fiber deposition (figure 1b). The polymeric hollow
cylinder had an outer diameter of 6 mm, a wall thickness of 1 mm
and a height of 6 mm. In both design A and B, the whole constructs
were immersed again in the DBM gel and freeze-dried. Figure 1
illustrates the principle of the assembling procedure.
Fabrication of the Bone Compartment Scaffolds
Polymeric 3DFM Matrix. 1000PEOT70PBT30 3DFM
scaffolds were manufactured with a Bioplotter device (Envisiontec
GmbH, Germany), essentially an XYZ plotter device as previously
described [30]. The device was modified to extrude highly viscous
polymeric fibers. The polymer was put in a stainless steel syringe and
heated at a temperature T=190uC through a thermoset cartridge
unit, fixed on the ‘‘X’’-mobile arm of the apparatus. When the
molten phase was achieved, a nitrogen pressure of 5 bars was applied
to the syringe through a pressurized cap. The scaffold models were
loaded on the Bioplotter computer aided manufacturing (CAM,
PrimCAM, Switzerland) software and deposited layer by layer,
through the extrusion of the polymer on a stage as a fiber. The
deposition speed was set to 300 mm/min. Scaffolds were then
characterized by the fiber diameter (through the nozzle diameter),
the spacing between fibers in the same layer, the layer thickness and
the configuration of the deposited fibers within the whole
architecture. In design A, the nozzle used was a stainless steel Luer
Lock needle with internal diameter (ID) of 400 mm, shortened to a
length of 16.2 mm. The fiber spacing was set to 1650 mm, while the
layer thickness to 225 mm. A 0-90 scaffold architecture was chosen,
where fibers were deposited with 90u orientation steps between
successive layers. In design B, the hollow cylindrical scaffold was
fabricated with a similar nozzle with respect than design A, but with
a smaller ID of 250 mm. The fiber spacing was decreased to 600 mm,
and the layer thickness to 150 mm, while the fiber deposition
architecture was maintained as a 0-90 architecture.
Ceramic Particles. Porous BCP designed particles were
fabricated by an indirect rapid prototyping technique. First
negative masks were designed with computer aided design
(CAD) software (RhinocerosH) and fabricated with an acrylic
photopolymerizable resin by photolithography (PreFAB,
Envisiontec, Germany). The masks were then filled with a BCP
slurry made by adding 32.8 grams of calcinated BCP powder
(20 hours in an oven at 1000uC), 14.2 grams of not calcinated
BCP powder, 20 grams of demineralized water, 1.2 grams of
methylcellulose solution (2% w/v methylcellulose in demineralized
water), 2.2 grams of ammonia, and 14.1 grams of 300–500 mm
sieved naphthalene particles, resulting in a 30% macro porosity of
the BCP particles. The components were blended and vigorously
stirred with a mixer for approximately 30 minutes, until a
homogeneous slurry was obtained. The BCP particles were then
obtained by debonding and sintering in a furnace (Nabertherm,
Germany) at T= 1150uC. Irregular BCP particles with an average
size between 1.4 mm and 2 mm were also used. These latter
particles were fabricated by hydrogen peroxide foaming, as
described elsewhere [14]. BCP particles were press fitted in the
pores of the 3DF matrix by exploiting the swelling behavior of
1000PEOT70PBT30. The polymeric matrix was left in
demineralized water for 24 hours to allow swelling prior to
insertion of the BCP particles.
3D Hybrid Scaffold Assembly. DBM gel was obtained by
mixing 2 grams of DBM powder into 80 grams of methanol
solution (4.75% volume/volume in demineralized water). DBM
foams were fabricated by placing the gel in square molds and
freeze-drying (Virtis 25 SRC, The Netherlands). The scaffolds
were finally immersed in the DBM gel and placed for 1 hour
under vacuum (0.01 mbar) to let the gel impregnate the porous
polymeric matrix and the BCP particles. After infiltration the final
construct was freeze-dried to obtain a porous DBM matrix
infiltrating and surrounding the scaffolds. This resulted in a final
hybrid scaffold thickness of approximately 6 mm for each design.
3D Osteochondral Scaffolds Fabrication. The
300PEOT55PBT45 cartilage compartment of the osteochondral
scaffold was deposited directly on top of the bone assembled 3D
hybrid scaffold by 3DF. In a similar process to what previously
explained, the polymer was placed in the extrusion syringe and
heated through the thermoset cartridge to reach its molten state at
T= 210uC. A nitrogen pressure of 5 bars was applied to extrude
the polymeric fibers from a nozzle with an ID of 250 mm and a
length of 16.2 mm. The fiber spacing was set to 600 mm, and the
layer thickness to 150 mm, while the fiber deposition architec-
ture was maintained as a 0-90 architecture. The fibers were
deposited at a speed of 230 mm/min. Having the two PEOT/
PBT compositions (bone= 1000PEOT70PBT30–cartilage =
300PEOT55PBT45) different swelling properties, osteochondral
scaffolds with and without an interlocking fibrous system were
fabricated to assess the interface resistance of the construct. The
interlocking system was made of intertwined concentric
1000PEOT70PBT30 and 300PEOT55PBT45 fibers at the
interface between the bone and the chondral parts of the
construct. The concentric fibers were extruded from needles
with ID and length as above described. The fiber spacing was set
to 800 mm, and the layer thickness to 135 mm. The fiber spacing
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was chosen to obtain a precise interlock of the fibers after swelling.
The resulting osteochondral scaffolds had a diameter of 6 mm and
a height of approximately 8 mm.
Scaffolds Characterization. Cylindrical plugs of 6 mm in
diameter by 6 mm in height were taken as samples for
characterization (n = 3). The constructs were analyzed with an
optical microscope (OM) to assess their integrity over time and by
scanning electron microscopy (SEM) analysis with a Philips XL 30
ESEM-FEG. Samples were gold sputter coated (Carringdon)
before SEM analysis. The porosity of the 3DF cartilage scaffold
and of the bone scaffold in its separated components and as a final
whole construct was experimentally measured by analyzing the
mass and the volume of each structure, as:
P~1{
M
V
: 1
r
ð1Þ
where M and V are the measured mass and volume of the scaffolds
components, while r is the specific density of the materials
(1.25 g/cm3 for 1000PEOT70PBT30, 3.15 g/cm3 for BCP, and
assumed to be 1 g/cm3 for DBM, since the mineral component
was extracted). The composition of BCP particles was analyzed by
x-ray diffraction (XRD) (Rigaku Miniflex, China) and Fourier
Transform Infrared analysis (FTIR) (Spectrum 1000, Perkin
Elmer, USA).
For the bone hybrid construct, the weight and volume
percentage of BCP included in each scaffold was also measured
as the ratio between the BCP particles weight and volume and the
weight and volume of the final construct, respectively (Supporting
Information, Table S1).
Mechanical Characterization of the Bone Hybrid
Scaffolds. A DMA instrument (Perkin Elmer 7e) was used to
evaluate the bending and compressive dynamic stiffness of the 3D
assembled scaffolds of the bone compartment and of the single
biomaterials used (n = 3). In the dynamic bending test, three slabs
of 15 mm in length by 5 mm in width by 6 mm in height were
used as samples. In the case of the hybrid constructs, only scaffolds
from design A were tested in the bending configuration as the
intrinsic construction of scaffolds in design B did not allow for their
bending characterization. A 3-point bending test was chosen for
the characterization. Scaffolds were loaded with a dynamic force
varying from 350 mN to 450 mN. A ramp of 5 mN/min at a
constant frequency of 1Hz was applied. A lower range of forces
was applied with respect to the compressive dynamic test to
prevent sample deformation that impinged with the test setting.
In the compressive dynamic test, for each hybrid design and for
each single biomaterial used three cylindrical samples of 6 mm in
diameter by approximately 6 mm in height were tested.
Cylindrical fixtures were chosen to test the specimens and evaluate
their behavior as a whole structure along their compression axis, in
the ‘‘z-direction’’. Scaffolds were loaded with a dynamic force
varying from 3.5N to 4.5N. A ramp of 50 mN/min at a constant
frequency of 1Hz was used. In the two test configurations, the
dynamic stiffness, or storage modulus E9, was calculated in the
elastic region of the composites. The theoretical modulus as
proposed by the Reuss-Voigt model for a composite was also
calculated [50]. In this case we assumed the ceramic particles as
mainly oriented along the longitudinal direction where compres-
sion occurs. The modulus can then be calculated as:
E~EiVizEmVm ð2Þ
where E is the modulus of the final construct, Ei and Vi are the
modulus and the volume fraction of the inclusions (here considered
as the BCP particles), while Em and Vm are the modulus and the
volume fraction of the polymeric matrix.
The stress and deformation at break were measured with a Zwick
Z050 mechanical testing apparatus (Zwick, Germany), in a failure
test under compression with a crosshead speed of 1 mm/min.
Bone marrow isolation and cell expansion. Goat bone
marrow cells (gBMCs) were isolated and culture expanded as
described previously [51]. Briefly, bone marrow aspirates from the
iliac wing of Dutch milk goats were plated in tissue culture flasks
(56105 nucleated cells/cm2) and cultured in expansion medium
containing a-Modified eagle medium supplemented with 15%
fetal bovine serum (FBS), 1% Penicillin/Streptomycin, 0.1 mM
ascobate-2- phosphate acid and 2 mM L-Glutamine until reaching
80% confluence. gBMCs were harvested using 0.25% trypsin-
EDTA, counted and replated at 1000 cells/cm2. Cells were
cultured in monolayer in a humidified atmosphere with 5%CO2 at
37uC. Medium was changed every 2–3 days. When reaching 80%
confluence again, cells were trypsinated, washed twice in
phosphate buffer saline (PBS) solution and counted using a
Burker turk counting chamber.
Cell seeding. Osteochondral grafts were incubated in
expansion medium 48 h prior to the implantation. Four samples
without cells served as controls. For the cell-based constructs two
different methods were used to seed the two different parts of the
osteochondral graft. For the osseous part, gBMCs were seeded at a
density of 2.56106 cells/graft onto the BCP component 4 h prior
to the implantation. For the chondral component 48 h prior to the
implantation cells were incubated in a 24-well plate at a cell
density of 16106 cells/well in Dulbecco’s modified eagle medium
supplemented with 1% penicillin/streptomycin, 1% ITS+ (insulin,
transferring, selenious acid), 100 nM dexamethasone, 50 mg/ml
ascorbic acid-2-phosphate, 100 mg/ml sodium pyruvate, 40 mg/
ml proline and 10ng/ml transforming growth factor (TGF) b1
(R&D Systems, Abington, UK). Prior to implantation cells of five
wells were collected, spun down at 300g for 30 seconds and
supernatant was removed. Cells were resuspended in 50 ml
MatrigelH (BD Bioscience, Alphen aan den Rijn, The
Netherlands) and placed into the pores of the chondral part of
the graft (total of 56106 cells/graft). Samples were incubated for
20 minutes at 37uC in order to let a gel be formed.
Implantation. Animals were housed at the Central Laboratory
Animal Institute (Utrecht University, The Netherlands). All animal
experiments have been approved by the local Animal Care and Use
committee (DEC) and performed in adherence to the local and
national ethics guidelines. The animals were acclimated for a
minimum of 5 days under the same conditions as the actual test. The
animals were housed in micro isolation polycarbonate cages with
sterile contact bedding, supplied with irradiated, certified
commercial feed and autoclaved, potable water.
To assess osteoinductivity, hybrid scaffolds were implanted
intramuscularly in (n = 3) 2–3 months old male rats (Wistar,
Charles River). Each rat received one intramuscular implants in
the leg. The animals were anesthesized and prepared for surgery.
With sharp and blunt dissection, a pocket was created in the femur
bicep (hamstring) muscle. The scaffold was placed into the pocket
and the muscle pocket and skin was suture closed. The animals
were recovered from the anesthesia and retuned to their cages. All
animals were observed daily for abnormal clinical signs. After 4
weeks the animals were sacrificed and the implants removed.
To assess osteoconductivity, hybrid scaffolds were implanted in an
ulna defect in (n=4) of six-month-old female New Zealand White
rabbits. Animals were kept in separate cages, fed a standard diet, and
allowed to move freely during the study. At surgery, the right
forearms were shaved and draped in a sterile fashion under general
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anesthesia with intravenous sodium pentobarbital (30 mg/kg of
body weight). An antibiotic (netilmicin 4 mg/kg of body weight) was
administered perioperatively. A 1.5 cm segmental bone defect was
created in the diaphysis of the right ulna using an oscillating saw
under irrigation with sterile saline solution. The periosteum attached
to the resected bone segment was removed, and the defect site was
irrigated with sterile PBS. After press-fit insertion of the implants the
fascia, subcutaneous tissues and skin were closed using absorbable
sutures and non-absorbable sutures, respectively. Animals were
allowed full weight-bearing activity immediately following the
surgery. Implants were evaluated after 6 weeks.
Tissue engineered osteochondral grafts and controls were
implanted into six weeks old male immunosufficient mice
(HdCpb:NMRI-nu, Harlan). Animals (n = 5) were operated under
aseptic conditions. After subcutaneous injection of 0,05 mg/kg
Temgesic for analgesia the mice were put under general inhalation
anesthesia using Isoflurane. Two subcutaneous pockets were
created on the dorsum of each mouse by blunt dissection. One
osteochondral graft was inserted per pocket. Evaluation was
assessed after 25 days.
Histological analysis. In rat and rabbit studies, scaffolds
were removed from the implantation site, fixed in 10% formalin
and dehydrated in a graded ethanol series. Samples were then
embedded in polymethylmethacrylate (Sigma, The Netherlands).
Histological sections of 7 mm were cut using a sawing microtome
(Leica, Germany) and stained with haematoxylin and eosin.
In the mice study, 25 days after implantation mice were
euthanized by CO2 asphyxiation. The implants were carefully
removed and fixed in 1,5% glutaraldehyde in 0,14 M sodium
cacodylate buffer for 24 h at 4uC. Following dehydration by
graded ethanol series specimens were embedded in polymethyl-
methacrylate. Histological sections of 10 mm were made using the
same microtome and stained with 1% methylene blue and 0,3%
basic fuchsin to visualize bone formation or 0,04% thionine to
distinguish cartilage like tissue formation.
Statistical Analysis
Statistical Analysis was performed using a Student’s t-test, where
the confidence level was set to 0.05 for statistical significance.
Values in this study are reported as mean and standard deviation.
Supporting Information
Table S1 BCP weight percentage included in the assembled
scaffolds depending on particle design.
Found at: doi:10.1371/journal.pone.0003032.s001 (0.28 MB TIF)
Table S2 Pore size and porosity distribution of the single
components and of the final scaffold constructs.
Found at: doi:10.1371/journal.pone.0003032.s002 (0.32 MB TIF)
Table S3 Comparison between the experimental and the
theoretical (Reuss-Voigt model) values of the storage moduli of
3D scaffolds with custom-designed assembled BCP particles.
Found at: doi:10.1371/journal.pone.0003032.s003 (0.33 MB TIF)
Figure S1 Influence of the BCP volume fraction on the bending,
compressive, and Reuss-Voigt moduli. Bending modulus:
r2 = 0.96; Reuss-Voigt modulus: r2 = 0.99; compressive modulus:
r2 = 0.87.
Found at: doi:10.1371/journal.pone.0003032.s004 (0.66 MB TIF)
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